These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33296553)

  • 1. The additive efficacy of therapeutic low-intensity pulsed ultrasound in the treatment of vitiligo: A randomized, left-right comparison clinical trial.
    Liao YH; Chen WS; Jee SH
    Dermatol Ther; 2021 Jan; 34(1):e14648. PubMed ID: 33296553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2015; 81(6):600-5. PubMed ID: 26515839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Targeted High-Intensity Medium-Band (304-312 nm) Ultraviolet B Light in Pediatric Vitiligo.
    Dong DK; Pan ZY; Zhang J; Lu XF; Jin C; Tao SQ; Yang LJ
    Pediatr Dermatol; 2017 May; 34(3):266-270. PubMed ID: 28318054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: evaluation of variables affecting therapeutic success.
    Hartmann A; Schmidt-Habel A; Löhberg L; Zajitschek J; Englbrecht M; Eichner S; Schuler G
    Eur J Dermatol; 2014; 24(5):551-9. PubMed ID: 25445089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
    Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
    J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the potential interference of camouflage on the treatment of vitiligo: An observer-blinded self-controlled study.
    Li M; Wang F; Ding X; Xu Q; Du J
    Dermatol Ther; 2021 Jan; 34(1):e14545. PubMed ID: 33190372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of excimer laser (308 nm) for vitiligo at different body sites.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):558-64. PubMed ID: 16684284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G; Kanwar AJ; Singh S; Parsad D
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
    Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
    Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled pilot trial of low-intensity pulsed ultrasound therapy for refractory angina pectoris.
    Shindo T; Ito K; Ogata T; Kurosawa R; Eguchi K; Kagaya Y; Hanawa K; Hasebe Y; Nishimiya K; Shiroto T; Takahashi J; Okumura Y; Noguchi T; Ozaki Y; Daida H; Hagiwara N; Masuyama T; Chikamori T; Fukumoto Y; Tsujita K; Kanai H; Yasuda S; Shimokawa H
    PLoS One; 2023; 18(6):e0287714. PubMed ID: 37352324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo.
    Zhang XY; He YL; Dong J; Xu JZ; Wang J
    Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):138-42. PubMed ID: 20584252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.